176 related articles for article (PubMed ID: 25195599)
21. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
22. miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.
Liu P; Hu Y; Ma L; Du M; Xia L; Hu Z
Biomed Pharmacother; 2015 Oct; 75():51-7. PubMed ID: 26463631
[TBL] [Abstract][Full Text] [Related]
23. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
Kang K; Zhang J; Zhang X; Chen Z
Oncol Rep; 2018 Jan; 39(1):401-410. PubMed ID: 29115540
[TBL] [Abstract][Full Text] [Related]
25. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
26. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
27. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
Rashed MH; Kanlikilicer P; Rodriguez-Aguayo C; Pichler M; Bayraktar R; Bayraktar E; Ivan C; Filant J; Silva A; Aslan B; Denizli M; Mitra R; Ozpolat B; Calin GA; Sood AK; Abd-Ellah MF; Helal GK; Berestein GL
Oncotarget; 2017 Mar; 8(12):20145-20164. PubMed ID: 28423620
[TBL] [Abstract][Full Text] [Related]
28. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
29. miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.
Wang N; Liang H; Zhou Y; Wang C; Zhang S; Pan Y; Wang Y; Yan X; Zhang J; Zhang CY; Zen K; Li D; Chen X
PLoS One; 2014; 9(8):e105570. PubMed ID: 25140799
[TBL] [Abstract][Full Text] [Related]
30. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
31. MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.
Qiu HJ; Lu XH; Yang SS; Weng CY; Zhang EK; Chen FC
Biomed Pharmacother; 2016 Aug; 82():117-23. PubMed ID: 27470346
[TBL] [Abstract][Full Text] [Related]
32. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
33. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
Li R; Zhang L; Jia L; Duan Y; Li Y; Wang J; Bao L; Sha N
PLoS One; 2014; 9(4):e94855. PubMed ID: 24722758
[TBL] [Abstract][Full Text] [Related]
35. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels.
Sun R; Guo M; Fan X; Meng Q; Yuan D; Yang X; Yan K; Deng H
Biomed Res Int; 2020; 2020():9568976. PubMed ID: 33274232
[TBL] [Abstract][Full Text] [Related]
37. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
38. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
Cao M; Hou D; Liang H; Gong F; Wang Y; Yan X; Jiang X; Wang C; Zhang J; Zen K; Zhang CY; Chen X
Eur J Cancer; 2014 Mar; 50(5):1013-24. PubMed ID: 24456795
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
[TBL] [Abstract][Full Text] [Related]
40. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]